Medacta Int’l opens US HQ in Franklin, Tennessee

Medacta USA is a subsidiary of Medacta Int’l, specialists in the design and production of innovative joint replacement and spine surgery products.


In late July 2019, Medacta officials opened its U.S. headquarters in Franklin, Tennessee. Medacta USA is a subsidiary of Medacta International, a global company specializing in the design and production of innovative joint replacement and spine surgery products.

Medacta USA will invest $2.5 million and create more than 50 jobs in Franklin. The new U.S. headquarters at 6640 Carothers Pkwy, Suite 420, Franklin, Tennessee, will house the company’s Total Joint (hip, knee & shoulder), Spine & Sports Medicine divisions serving North America.

Established in 1999 in Switzerland, Medacta’s products and surgical techniques have made a significant impact in the global orthopedic market. Medacta is a pioneer in developing new offerings to support minimally invasive surgical techniques with a strong commitment to provide ongoing clinical education programs and products that enhance healthcare system sustainability worldwide.

“Today we take another step in our company’s growth evolution,” says Francesco Siccardi, CEO of Medacta International. “This year Medacta is celebrating its 20-year anniversary and recently becoming a public company with shares available for purchase on the Swiss Exchange. In 2018, we were among the fastest growing orthopedic companies, and opening our North American headquarters here in Franklin, Tennessee is a testament to the impact we made on the orthopedic market globally. We are grateful for the community’s warm welcome and look forward to becoming an active and visible member of it.”

Medacta’s mission is to transform the patient experience by advancing surgical approaches, implants and instruments through responsible innovation and meticulous design. The company’s innovation began with minimally invasive techniques and has evolved into personalized solutions for every patient. Today, Medacta utilizes cutting-edge technologies such as 3D printing, invests in medical education, research and development, and collaborates with surgeons and universities worldwide.